Why $BD1 will go higher

Will $BD1 go higher after climbing 58% from last week's low of 1.9c? I sense yes. Why?

1. Market will acknowledge the feat of director/chief shareholder Dr Irmgard Irminger-Finger in devising a simple blood test that accurately detects the presence of cancer in 95% of lung cancer samples tested.

2. Preliminary BARD1 Proof-of-Concept results deemed “exceptional” .

3. Results to be detailed in a soon-to-be-published scientific paper.

4. Simple lung cancer blood test tech may also accurately detect breast cancer, ovarian cancer and colon cancer.

5. Indications that BARD1 is immunogenic, capable of slowing ovarian tumor growth and may be developed for vaccination.
6. $BD1 R&D spending to rise five-fold in Sept quarter as analysis using Meso Scale Diagnostics’
technology cranks up.

7. At market close for the weekend BD1 buyers outnumber sellers by 8 to 1. Ratio of shares bid/shares offered stands at ~14 to 1.

8. Eight on-market buying operations in seven weeks by insider Executive Chairman Peter Gunzburg.

Gunzburg associates Supergun and Worldwise Enterprises have hoisted their total stake 30% to ~30m shares. In doing so they’ve scored a paper profit of near 50%.

This result may further encourage Peter Gunzburg, a smart money man with a broking background.

If/when Gunzburg announces market buying at 3c or above, he seems set to further propel the SP.